| Literature DB >> 36196254 |
Zhenghao Cai1,2, Haiqin Song1,2, Zhenfeng Huang3, Abraham Fingerhut1,2,4, Ximo Xu1,2, Hao Zhong1,2, Zhigang Li5, Yingjie Zhang6, Dachong Sha7, Dandan Bao8, Haibo Wang9, Binghua Cai10, Shangbo Hua11, Yanhui Zhang12, Jianguang Sun13, Ke Ye14, Jianwen Li2, Yong Lu15, Bo Feng1.
Abstract
Background: The multi-site practice (MSP) policy has been practiced in China over 10 years. This study aimed to investigate the safety and feasibility of performing laparoscopic surgery for colorectal cancer (LSCRC) and gastric cancer (LSGC) under the Chinese MSP policy.Entities:
Keywords: gastrointestinal tumors; health policy; laparoscopic surgery; public health; quality in health care
Year: 2022 PMID: 36196254 PMCID: PMC9522381 DOI: 10.1093/gastro/goac046
Source DB: PubMed Journal: Gastroenterol Rep (Oxf)
Clinicopathological characteristics of 690 patients undergoing laparoscopic surgery for colorectal cancer
| Characteristic | Original hospital | MSP institutions | |
|---|---|---|---|
| ( | ( |
| |
| Sex, | 0.478 | ||
| Male | 221 (63.3) | 207 (60.7) | |
| Female | 128 (36.7) | 134 (39.3) | |
| Age (years), median (quartile) | 64 (55–70) | 66 (55–72) |
|
| Body mass index (kg/m2), median (quartile) | 23.0 (21.2–25.0) | 23.4 (21.9–25.3) | 0.195 |
| Hypoalbuminemia, |
| ||
| No | 308 (88.3) | 241 (70.7) | |
| Yes | 41 (11.7) | 100 (29.3) | |
| ASA classification, | 0.812 | ||
| I–II | 342 (98.0) | 335 (98.2) | |
| III | 7 (2.0) | 6 (1.8) | |
| Neoadjuvant chemoradiotherapy, |
| ||
| No | 318 (91.1) | 336 (98.5) | |
| Yes | 31 (8.9) | 5 (1.5) | |
| Tumor location, | (Missing = 3) | 0.558 | |
| Mid-low rectum | 80 (22.9) | 76 (22.5) | |
| High rectum and rectosigmoid junction | 156 (44.7) | 139 (41.1) | |
| Left colon | 24 (6.9) | 32 (9.5) | |
| Right colon | 89 (25.5) | 91 (26.9) | |
| Extent of coloproctectomy, | (Missing = 7) | 0.088 | |
| Proctectomy | 235 (67.3) | 204 (61.1) | |
| Colectomy | 114 (32.7) | 130 (38.9) | |
| Operative time (min), median (quartile) | 129 (105–160) | 135 (120–165) |
|
| Intraoperative blood loss (mL), median (quartile) | 20 (10–20) | 50 (20–50) |
|
| Intraoperative blood loss > 300 mL, |
| ||
| No | 349 (100.0) | 332 (97.4) | |
| Yes | 0 (0.0) | 9 (2.6) | |
| Conversion to open surgery, | 0.373 | ||
| No | 345 (98.9) | 340 (99.7) | |
| Yes | 4 (1.1) | 1 (0.3) | |
| Post-operative hospital stay (days), median (quartile) | 7 (6–8) | 12 (10–14) |
|
| Post-operative complications, | 0.895 | ||
| No | 309 (88.5) | 303 (88.9) | |
| Yes | 40 (11.5) | 38 (11.1) | |
| Tumor size (cm), median (quartile) | 4.0 (3.0–5.0) | 4.0 (3.0–5.0) |
|
| pTNM stage, | (Missing = 2) | (Missing = 3) | 0.280 |
| I | 85 (24.5) | 64 (18.9) | |
| II | 109 (31.4) | 128 (37.9) | |
| III | 128 (36.9) | 134 (39.6) | |
| IV | 25 (7.2) | 12 (3.6) | |
| Number of lymph-node yield, median (quartile) | 15 (13–19) | 15 (12–18) |
|
| Adequate lymph-node yield, | (Missing = 1) | (Missing = 1) |
|
| Yes (≥12) | 308 (88.5) | 268 (78.8) | |
| No (<12) | 40 (11.5) | 72 (21.2) | |
| Resection margin ≥ 5 mm, | 0.451 | ||
| Yes | 344 (98.6) | 339 (99.4) | |
| No | 5 (1.4) | 2 (0.6) |
MSP, multi-site practice; ASA, American Society of Anesthesiologists.
Clinicopathological characteristics of 391 patients undergoing LSGC
| Characteristic | Original hospital | MSP institutions | |
|---|---|---|---|
| ( | ( |
| |
| Sex, | 0.685 | ||
| Male | 154 (68.8) | 118 (70.7) | |
| Female | 70 (31.2) | 49 (29.3) | |
| Age (years), median (quartile) | 63 (56–68) | 67 (59–72) |
|
| BMI (kg/m2), median (quartile) | 23.1 (20.6–25.3) | 22.7 (20.9–24.6) | 0.327 |
| Hypoalbuminemia, |
| ||
| No | 201 (89.7) | 136 (81.4) | |
| Yes | 23 (10.3) | 31 (18.6) | |
| ASA classification, | 0.590 | ||
| I–II | 215 (96.0) | 162 (97.0) | |
| III | 9 (4.0) | 5 (3.0) | |
| NCT, | 0.574 | ||
| No | 217 (96.9) | 160 (95.8) | |
| Yes | 7 (3.1) | 7 (4.2) | |
| Tumor location, | (Missing = 1) | 0.888 | |
| Stomach | 179 (80.3) | 135 (80.8) | |
| EG junction | 44 (19.7) | 32 (19.2) | |
| Extent of gastrectomy, | 0.312 | ||
| Partial gastrectomy | 157 (70.1) | 109 (65.3) | |
| Total gastrectomy | 67 (29.9) | 58 (34.7) | |
| Operative time (min), median (quartile) | 180 (156–206) | 180 (150–225) | 0.377 |
| Blood loss (mL), median (quartile) | 50 (20–50) | 50 (50–100) |
|
| Blood loss > 300 mL, |
| ||
| No | 220 (98.2) | 158 (94.6) | |
| Yes | 4 (1.8) | 9 (5.4) | |
| Conversion to open surgery, | 0.182 | ||
| No | 224 (100.0) | 165 (98.8) | |
| Yes | 0 (0.0) | 2 (1.2) | |
| Post-operative stay (days), median (quartile) | 8 (7–10) | 13 (11–16) |
|
| Post-operative complications, | 0.464 | ||
| No | 190 (84.8) | 146 (87.4) | |
| Yes | 34 (15.2) | 21 (12.6) | |
| Tumor size (cm), median (quartile) | 3.1 (2.0–4.8) | 3.5 (2.5–5.0) |
|
| pTNM stage, | (Missing = 1) | 0.231 | |
| I | 85 (37.9) | 50 (30.1) | |
| II | 50 (22.3) | 51 (30.7) | |
| III | 79 (35.3) | 58 (34.9) | |
| IV | 10 (4.5) | 7 (4.2) | |
| Number of LN yield, median (quartile) | 25 (19–29) | 23 (16–30) | 0.064 |
| Adequate LN yield, | (Missing = 1) |
| |
| Yes (>16) | 202 (90.2) | 132 (79.5) | |
| No (<15) | 22 (9.8) | 34 (20.5) | |
| Resection margin ≥ 5 mm, | 0.454 | ||
| Yes | 214 (95.5) | 162 (97.0) | |
| No | 10 (4.5) | 5 (3.0) |
LSGC, laparoscopic surgery for gastric cancer; MSP, multi-site practice; BMI, body mass index; ASA, American Society of Anesthesiologists; NCT, neoadjuvant chemoradiotherapy; EG junction, esophagogastric junction; LN, lymph node.
Incidence of post-operative complications after LSCRC and LSGC
| Complication ( | Original hospital | MSP institutions | ||
|---|---|---|---|---|
| LSCRC ( | LSGC ( | LSCRC ( | LSGC ( | |
| Anastomotic bleeding | 1 (0.3) | 1 (0.4) | 2 (0.6) | 2 (1.2) |
| Intra-abdominal bleeding | 1 (0.3) | 2 (0.9) | 1 (0.3) | 0 |
| AL | 20 (5.7) | 8 (3.6) | 7 (2.1) | 6 (3.6) |
| Deep SSI | 6 (1.7) | 11 (4.9) | 5 (1.5) | 2 (1.2) |
| Wound infection | 2 (0.6) | 6 (2.7) | 5 (1.5) | 1 (0.6) |
| Urinary infection | 6 (1.7) | 0 | 3 (0.9) | 0 |
| Respiratory infection | 0 | 6 (2.7) | 4 (1.2) | 5 (3.0) |
| lymphatic leakage | 0 | 0 | 3 (0.9) | 4 (2.4) |
| Intestinal obstruction | 3 (0.9) | 1 (0.4) | 10 (2.9) | 1 (0.6) |
| Delayed gastric emptying | 1 (0.3) | 2 (0.9) | 0 | 5 (3.0) |
| Cardiovascular events | 0 | 2 (0.9) | 0 | 0 |
| Organ dysfunction | 1 (0.3) | 2 (0.9) | 2 (0.6) | 1 (0.6) |
| Overall | 40 (11.5) | 34 (15.2) | 38 (11.1) | 21 (12.6) |
LSCRC, laparoscopic surgery for colorectal cancer; LSGC, laparoscopic surgery for gastric cancer; MSP, multi-site practice; AL, anastomotic leakage; SSI, surgical site infection.
Comparison of patient characteristics undergoing LSCRC between different MSP institutions
| Characteristic | Surgical skill competence | Operative instrument competence | Perioperative multi-discipline competence | ||||||
|---|---|---|---|---|---|---|---|---|---|
| With | Without | With | Without | With | Without | ||||
| ( | ( |
| ( | ( |
| ( | ( |
| |
| Sex, | 0.333 |
| 0.671 | ||||||
| Male | 178 (59.7) | 29 (67.4) | 182 (63.0) | 27 (51.9) | 139 (61.5) | 68 (59.1) | |||
| Female | 120 (40.3) | 14 (32.6) | 107 (37.0) | 25 (48.1) | 87 (38.5) | 47 (40.9) | |||
| Age (years), median (quartile) | 66 (56–73) | 62 (49–70) |
| 66 (55–72) | 66 (55–73) | 0.866 | 65 (55–72) | 67 (55–74) | 0.169 |
| Operative time (min), median (quartile) | 135 (110–160) | 155 (130–195) |
| 130 (115–157) | 195 (128–220) |
| 135 (120–165) | 135 (110–165) | 0.778 |
| Blood loss (mL), median (quartile) | 30 (20–50) | 50 (50–55) |
| 45 (20–50) | 50 (30–95) |
| 50 (20–50) | 50 (20–50) | 0.282 |
| Blood loss > 300 mL, |
| 0.144 | 0.723 | ||||||
| No | 293 (98.3) | 39 (90.7) | 283 (97.9) | 49 (94.2) | 219 (96.9) | 113 (98.3) | |||
| Yes | 5 (1.7) | 4 (9.3) | 6 (2.1) | 3 (5.8) | 7 (3.1) | 2 (1.7) | |||
| Post-operative hospital stay (days), median (quartile) | 12 (10–14) | 12 (10–16) | 0.273 | 12 (10–14) | 12 (10–16) | 0.471 | 12 (10–14) | 12 (10–14) | 0.794 |
| Post-operative complications, | 0.602 | 0.291 | 0.426 | ||||||
| No | 266 (89.3) | 37 (86.0) | 259 (89.6) | 44 (84.6) | 203 (89.8) | 100 (87.0) | |||
| Yes | 32 (10.7) | 6 (14.0) | 30 (10.4) | 8 (15.4) | 23 (10.2) | 15 (13.0) | |||
| Tumor size (cm), median (quartile) | 4.2 (3.0–5.0) | 4.0 (3.0–4.6) |
| 4.0 (3.0–5.0) | 4.0 (3.0–5.4) | 0.804 | 4.5 (3.0–5.2) | 4.0 (3.0–5.0) | 0.115 |
| Number of LN yield, median (quartile) | 15 (11–18) | 14 (11–19) | 0.878 | 15 (11–18) | 14 (11–18) | 0.924 | 16 (12–21) | 12 (10–15) |
|
| Adequate LN yield, | (Missing =1) | 0.721 | (Missing = 1) | 0.458 | (Missing = 1) |
| |||
| Yes (>12) | 235 (79.1) | 33 (76.7) | 225 (78.1) | 43 (82.7) | 187 (83.1) | 81 (70.4) | |||
| No (<11) | 62 (20.9) | 10 (23.3) | 63 (21.9) | 9 (17.3) | 38 (16.9) | 34 (29.6) | |||
LSCRC, laparoscopic surgery for colorectal cancer; MSP, multi-site practice; LN, lymph node.
Comparison of patient characteristics undergoing LSGC between different MSP institutions
| Surgical skill competence | Operative instrument competence | Perioperative multi-discipline competence | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | With | Without | With | Without | With | Without | |||
| ( | ( |
| ( | ( |
| ( | ( |
| |
| Sex, | 0.114 | 0.346 | 0.063 | ||||||
| Male | 103 (73.0) | 15 (57.5) | 107 (71.8) | 11 (61.1) | 87 (75.0) | 31 (60.8) | |||
| Female | 38 (27.0) | 11 (42.3) | 42 (28.2) | 7 (38.9) | 29 (25.0) | 20 (39.2) | |||
| Age (years), median (quartile) | 68 (60–72) | 63 (51–69) |
| 67 (59–72) | 66 (61–74) | 0.928 | 67 (58–72) | 69 (60–72) | 0.458 |
| Operative time (min), median (quartile) | 180 (150–215) | 210 (168–253) |
| 180 (150–222) | 190 (150–240) | 0.751 | 180 (150–215) | 185 (150–235) | 0.551 |
| Blood loss (mL), median (quartile) | 50 (50–100) | 100 (50–200) |
| 50 (50–100) | 50 (100–150) | 0.074 | 50 (50–100) | 60 (50–100) | 0.254 |
| Blood loss > 300 mL, | 0.148 | 1.000 | 0.094 | ||||||
| No | 135 (95.7) | 23 (88.5) | 141 (94.6) | 17 (94.4) | 112 (96.6) | 46 (90.2) | |||
| Yes | 6 (4.3) | 3 (11.5) | 8 (5.4) | 1 (5.6) | 4 (3.4) | 5 (9.8) | |||
| Post-operative stay (days), median (quartile) | 13 (11–15) | 17 (14–20) |
| 13 (11–16) | 15 (12–17) | 0.391 | 13 (11–16) | 15 (11–20) | 0.259 |
| Post-operative complications, | 0.747 | 1.000 |
| ||||||
| No | 124 (87.9) | 22 (84.6) | 130 (87.2) | 16 (88.9) | 106 (91.4) | 40 (78.4) | |||
| Yes | 17 (12.1) | 4 (15.4) | 19 (12.8) | 2 (11.1) | 10 (8.6) | 11 (21.6) | |||
| Tumor size (cm), median (quartile) | 3.6 (2.5–5.0) | 3.0 (2.0–4.4) | 0.291 | 3.5 (2.5–5.0) | 3.0 (2.0–5.4) | 0.690 | 3.5 (2.5–5.3) | 4.0 (2.5–5.0) | 0.650 |
| Number of LN yield, median (quartile) | 23 (16–29) | 23 (16–35) | 0.489 | 23 (16–30) | 18 (16–26) | 0.292 | 25 (18–31) | 18 (15–24) |
|
| Adequate LN yield, | (Missing =1) | 0.863 | (Missing =1) | 0.753 | (Missing =1) |
| |||
| Yes (>16) | 111 (79.3) | 21 (80.8) | 119 (79.9) | 13 (76.5) | 99 (86.1) | 132 (79.5) | |||
| No (<15) | 29 (20.7) | 5 (19.2) | 30 (20.1) | 4 (23.5) | 16 (13.9) | 34 (20.5) | |||
LSGC, laparoscopic surgery for gastric cancer; MSP, multi-site practice; LN, lymph node.